CN102014910A - 在无食物条件下施用齐拉西酮的方法、剂型和试剂盒 - Google Patents

在无食物条件下施用齐拉西酮的方法、剂型和试剂盒 Download PDF

Info

Publication number
CN102014910A
CN102014910A CN2009801164839A CN200980116483A CN102014910A CN 102014910 A CN102014910 A CN 102014910A CN 2009801164839 A CN2009801164839 A CN 2009801164839A CN 200980116483 A CN200980116483 A CN 200980116483A CN 102014910 A CN102014910 A CN 102014910A
Authority
CN
China
Prior art keywords
ziprasidone
dosage form
solid oral
oral dosage
auc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2009801164839A
Other languages
English (en)
Chinese (zh)
Inventor
威廉·J·库拉托洛
斯科特·M·赫比格
阿维纳什·G·托姆布雷
杰明·C·尚
谢里·L·香布林
蒂莫西·卢卡斯
威廉·B·考德威尔
德韦恩·T·弗里森
戴维·K·莱昂
克里斯托弗·D·克雷格
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of CN102014910A publication Critical patent/CN102014910A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN2009801164839A 2008-03-07 2009-03-04 在无食物条件下施用齐拉西酮的方法、剂型和试剂盒 Pending CN102014910A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3494708P 2008-03-07 2008-03-07
US61/034,947 2008-03-07
PCT/IB2009/000442 WO2009109844A1 (en) 2008-03-07 2009-03-04 Methods, dosage forms, and kits for administering ziprasidone without food

Publications (1)

Publication Number Publication Date
CN102014910A true CN102014910A (zh) 2011-04-13

Family

ID=40720011

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009801164839A Pending CN102014910A (zh) 2008-03-07 2009-03-04 在无食物条件下施用齐拉西酮的方法、剂型和试剂盒

Country Status (15)

Country Link
US (1) US20110002989A1 (https=)
EP (1) EP2280711A1 (https=)
JP (1) JP2009215293A (https=)
KR (1) KR20100131477A (https=)
CN (1) CN102014910A (https=)
AR (1) AR070964A1 (https=)
AU (1) AU2009220925A1 (https=)
BR (1) BRPI0909818A2 (https=)
CA (1) CA2719115A1 (https=)
IL (1) IL207792A0 (https=)
MX (1) MX2010009844A (https=)
RU (1) RU2010135831A (https=)
TW (1) TW200950783A (https=)
WO (1) WO2009109844A1 (https=)
ZA (1) ZA201005905B (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106714785A (zh) * 2014-09-19 2017-05-24 宝洁公司 用于制备具有活性包衣的芯的方法
CN107714669A (zh) * 2016-08-11 2018-02-23 广东东阳光药业有限公司 齐拉西酮缓释剂及其制备方法

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010082855A1 (en) * 2009-01-15 2010-07-22 Zaklady Farmaceutyczne Polpharma Sa Pharmaceutical compositions comprising ziprasidone free base or ziprasidone hydrochloride and the method for their preparation
US9510148B2 (en) * 2009-03-03 2016-11-29 Mobilitie, Llc System and method for wireless communication to permit audience participation
CN105492007A (zh) * 2013-05-03 2016-04-13 欣达克斯制药公司 癌症治疗方法
CA2919522C (en) 2013-07-30 2019-02-26 Gilead Connecticut, Inc. Formulation of syk inhibitors
EA029281B1 (ru) 2013-07-30 2018-03-30 Джилид Коннектикут, Инк. Полиморф ингибиторов syk
EP3076951B1 (en) * 2013-12-05 2020-09-30 Celal Albayrak Process for the production of drug formulations for oral administration
TWI662037B (zh) 2013-12-23 2019-06-11 美商基利科學股份有限公司 脾酪胺酸激酶抑制劑
US10474345B2 (en) * 2014-04-04 2019-11-12 Shawn SHEY User interfaces and methods for displaying content
ES3063790T3 (en) 2015-06-09 2026-04-20 Lonza Sales Ag Formulations to achieve rapid dissolution of drug from spray-dried dispersions in capsules
US11154510B2 (en) 2015-06-11 2021-10-26 Alrise Biosystems Gmbh Process for the preparation of drug loaded microparticles
CA3073871A1 (en) 2017-08-25 2019-02-28 Gilead Sciences, Inc. Polymorphs of syk inhibitors
CN113950479A (zh) 2019-02-22 2022-01-18 克洛诺斯生物股份有限公司 作为syk抑制剂的缩合吡嗪的固体形式

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002309172A1 (en) * 2001-06-22 2003-01-08 Pfizer Products Inc. Pharmaceutical compositions containing polymer and drug assemblies
KR20090080143A (ko) * 2003-09-02 2009-07-23 화이자 프로덕츠 인크. 지프라시돈의 지속 방출형 투여 형태
US7825106B2 (en) * 2003-09-03 2010-11-02 Agi Therapeutics Ltd. Modified release formulations and methods of treating inflammatory bowel disease
EP1703898A2 (en) * 2003-12-31 2006-09-27 Alpharma, Inc. Ziprasidone formulations
WO2005123086A2 (en) * 2004-06-11 2005-12-29 Dr. Reddy's Laboratories Ltd. Ziprasidone dosage form
CA2613474A1 (en) * 2005-06-20 2007-03-08 Elan Pharma International Limited Nanoparticulate and controlled release compositions comprising aryl-heterocyclic compounds

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106714785A (zh) * 2014-09-19 2017-05-24 宝洁公司 用于制备具有活性包衣的芯的方法
CN107714669A (zh) * 2016-08-11 2018-02-23 广东东阳光药业有限公司 齐拉西酮缓释剂及其制备方法

Also Published As

Publication number Publication date
US20110002989A1 (en) 2011-01-06
WO2009109844A1 (en) 2009-09-11
JP2009215293A (ja) 2009-09-24
IL207792A0 (en) 2010-12-30
BRPI0909818A2 (pt) 2015-10-06
CA2719115A1 (en) 2009-09-11
ZA201005905B (en) 2011-11-30
AU2009220925A1 (en) 2009-09-11
EP2280711A1 (en) 2011-02-09
MX2010009844A (es) 2010-09-30
RU2010135831A (ru) 2012-04-20
KR20100131477A (ko) 2010-12-15
TW200950783A (en) 2009-12-16
AR070964A1 (es) 2010-05-19

Similar Documents

Publication Publication Date Title
CN102014910A (zh) 在无食物条件下施用齐拉西酮的方法、剂型和试剂盒
US12447128B2 (en) Formulations of enzalutamide
RU2351316C2 (ru) Лекарственные формы с замедленным высвобождением зипразидона
US20110034478A1 (en) Oral Pharmaceutical Compositions in a Solid Dispersion Comprising Preferably Posaconazole and HPMCAs
JP5749247B2 (ja) 経口用徐放性固形製剤
CN114727949A (zh) Tyk2抑制剂的剂型
JP2025134801A (ja) オラパリブの溶解度及び生体利用効率が改善された組成物
HK1150392A (en) Methods, dosage forms, and kits for administering ziprasidone without food
CN113164455B (zh) 难溶性药物的固体分散体
HK40108713A (en) Formulations of enzalutamide
HK40116766A (en) Formulations of enzalutamide
HK40065232A (en) Formulations of enzalutamide
HK40037883A (en) Formulations of enzalutamide
HK40037883B (en) Formulations of enzalutamide

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1150392

Country of ref document: HK

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20110413

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1150392

Country of ref document: HK